Clarity Pharmaceuticals Ltd Financial Flexibility Index
Clarity Pharmaceuticals Ltd financial flexibility index. Clarity Pharmaceuticals Ltd (CU6) has a Financial Flexibility Index of -3.45x as of June 2026. Free cash flow of AU$-44.70 Million (operating CF AU$-44.75 Million minus capex AU$49.08K) represents -3% of total liabilities (AU$12.96 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Clarity Pharmaceuticals Ltd (2018–2026)
Financial flexibility index of Clarity Pharmaceuticals Ltd from 2018 to 2026. Historical Financial Flexibility Index trend for Clarity Pharmaceuticals Ltd across 9 annual periods. Explore CU6 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Clarity Pharmaceuticals Ltd Financial Flexibility Index by Year (2018–2026)
Clarity Pharmaceuticals Ltd financial flexibility index by year from 2018 to 2026. Year-by-year free cash flow to debt coverage for Clarity Pharmaceuticals Ltd. For the full cash flow conversion analysis, see CU6 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | -7.12x | AU$-92.24 Million | AU$-92.55 Million | AU$12.96 Million | ▼ -42.7% |
| 2025 | -4.99x | AU$-54.59 Million | AU$-54.77 Million | AU$10.94 Million | ▲ +2.7% |
| 2024 | -5.13x | AU$-42.73 Million | AU$-43.24 Million | AU$8.33 Million | ▼ -44.2% |
| 2023 | -3.56x | AU$-27.45 Million | AU$-27.50 Million | AU$7.72 Million | ▼ -105.9% |
| 2022 | -1.73x | AU$-13.10 Million | AU$-13.31 Million | AU$7.59 Million | ▲ +47.0% |
| 2021 | -3.26x | AU$-7.62 Million | AU$-7.68 Million | AU$2.34 Million | ▲ +54.2% |
| 2020 | -7.13x | AU$-6.82 Million | AU$-6.83 Million | AU$956.09K | ▼ -119.5% |
| 2019 | -3.25x | AU$-3.69 Million | AU$-3.71 Million | AU$1.14 Million | ▼ -86.3% |
| 2018 | -1.74x | AU$-1.49 Million | AU$-1.50 Million | AU$857.04K | — |